Who
Shelley B. Thunen
Director
Company insider
Files Form 4 as: Director, AEON Biopharma; Director, LENZ Therapeutics; Chief Financial Officer, RxSight; Director, Restoration Robotics; Chief Financial Officer, Endologix Inc /de/; EVP & CFO, Intralase.
In numbers
- Trades disclosed
- 177
- Buys
- 0
- Sells
- 14
- Bought
- $0
- Sold
- $9.6M
- Companies
- 6
- Companies where not an officer
- 3
- First trade
- 22 Feb 2006
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —222,684 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —222,684 at $0.00 | filing |
| 15 Jun 2026filed 15 Jun 2026 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,100 at $0.00 | filing |
| 15 Jun 2026filed 15 Jun 2026 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,100 at $0.00 | filing |
| 11 Jun 2025filed 11 Jun 2025 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,500 at $0.00 | filing |
| 21 May 2025filed 23 May 2025 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —308,641 at $0.00 | filing |
| 14 Apr 2025filed 15 Apr 2025 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code M | —6,405 at $0.00 | filing |
| 14 Apr 2025filed 15 Apr 2025 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,387 at $0.00 | filing |
| 14 Apr 2025filed 15 Apr 2025 | RXST RxSightMedical Devices | SEC FORM 4 Code M | $34K7,792 at $4.34 | filing |
| 27 Feb 2025filed 27 Feb 2025 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 1 Oct 2024filed 2 Oct 2024 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 1 Oct 2024filed 2 Oct 2024 | RXST RxSightMedical Devices | SEC FORM 4 Code M | $240K15,000 at $16.00 | filing |
| 1 Oct 2024filed 2 Oct 2024 | RXST RxSightMedical Devices | SEC FORM 4 Sold | $249K5,201 at $47.96 | filing |
| 1 Oct 2024filed 2 Oct 2024 | RXST RxSightMedical Devices | SEC FORM 4 Sold | $464K9,521 at $48.69 | filing |
| 1 Oct 2024filed 2 Oct 2024 | RXST RxSightMedical Devices | SEC FORM 4 Sold | $14K278 at $49.45 | filing |
| 31 Aug 2024filed 4 Sep 2024 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —96,210 at $0.00 | filing |
| 31 Aug 2024filed 4 Sep 2024 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —36,021 at $0.00 | filing |
| 7 Aug 2024filed 8 Aug 2024 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 15 Jul 2024filed 16 Jul 2024 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code M | —11,235 at $0.00 | filing |
| 15 Jul 2024filed 16 Jul 2024 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code M | —5,270 at $0.00 | filing |
News
RxSight Appoints Eye Care Industry Leaders to Drive Commercial TransformationRXST · manilatimes.net · 19 Oct 2026RxSight (NASDAQ:RXST) vs. Coloplast A/S (OTCMKTS:CLPBY) Head to Head AnalysisRXST · tickerreport.com · 14 Oct 2026Financial Survey: RxSight (NASDAQ:RXST) versus Envoy Medical (NASDAQ:COCH)RXST · themarketsdaily.com · 11 Oct 2026
0 headlines in the last 90 days name Shelley B. Thunen; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.